Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICIs) are the new standard of care in microsatellite instability-high (MSI-H)/deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC). Since tumor response dynamic parameters already shown a strong association with survival outcomes in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Fucà, Giovanni, Corti, Francesca, Ambrosini, Margherita, Intini, Rossana, Salati, Massimiliano, Fenocchio, Elisabetta, Manca, Paolo, Manai, Chiara, Daniel, Francesca, Raimondi, Alessandra, Morano, Federica, Corallo, Salvatore, Prisciandaro, Michele, Spallanzani, Andrea, Quarà, Virginia, Belli, Carmen, Vaiani, Marta, Curigliano, Giuseppe, Cremolini, Chiara, De Braud, Filippo, Di Bartolomeo, Maria, Zagonel, Vittorina, Lonardi, Sara, Pietrantonio, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051394/
https://www.ncbi.nlm.nih.gov/pubmed/33849927
http://dx.doi.org/10.1136/jitc-2021-002501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051394/
https://www.ncbi.nlm.nih.gov/pubmed/33849927
http://dx.doi.org/10.1136/jitc-2021-002501

Ejemplares similares